794535-38-9

Basic information

• Product Name: 1H-Carbazole-1-acetic acid, 9-[(1S)-1-(4-chlorophenyl)ethyl]-6-fluoro-2,3,4,9-tetrahydro-8-(methylsulf onyl)-, (1R)-
• CAS NO: 794535-38-9
• Molecular Formula: C23H23ClFNO4S
• Molecular Weight: 463.957
• Mol File: 794535-38-9.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: 1H-Carbazole-1-acetic acid, 9-[(1S)-1-(4-chlorophenyl)ethyl]-6-fluoro-2,3,4,9-tetrahydro-8-(methylsulf onyl)-, (1R)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Carbazole-1-acetic acid, 9-[(1S)-1-(4-chlorophenyl)ethyl]-6-fluoro-2,3,4,9-tetrahydro-8-(methylsulf onyl)-, (1R)-(794535-38-9)
• EPA Substance Registry System: 1H-Carbazole-1-acetic acid, 9-[(1S)-1-(4-chlorophenyl)ethyl]-6-fluoro-2,3,4,9-tetrahydro-8-(methylsulf onyl)-, (1R)-(794535-38-9)

Safety Data

• Hazardous Substances Data: 794535-38-9(Hazardous Substances Data)

Upstream product

• 3391-10-4 (R)-1-(4-chlorophenyl)ethan-1-ol 
• 99-91-2 para-chloroacetophenone 
• 571170-91-7 (2-bromo-4-fluorophenyl)hydrazine hydrochloride 
• 1003-98-1 2-bromo-4-fluoroaniline 
• 24731-17-7 ethyl 2-(2-oxocyclohexyl)acetate 
• 794535-41-4 Ethyl [(1R)-6-fluoro-8-(methylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-1-yl]acetate 
• 794535-40-3 (+/-)-ethyl [6-fluoro-8-(methylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-1-yl]-acetate 
• 571170-87-1 (+/-)-ethyl (8-bromo-6-fluoro-2,3,4,9-tetrahydro-1H-carbazol-1-yl)acetate 
• 794535-42-5 ethyl [(1R)-9-[(1S)-1-(4-chlorophenyl)ethyl]-6-fluoro-8-(methylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-1-yl]acetate 
• 64-19-7 acetic acid 
• 794535-44-7 ethyl [(1S)-9-[(1S)-1-(4-chlorophenyl)ethyl]-6-fluoro-8-(methylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-1-yl]acetate 

Downstream Products

• 878886-63-6 methyl ((1R)-6-fluoro-8-(methylsulfonyl)-9-((1S)-1-[4-(trifluoromethyl)phenyl]ethyl)-2,3,4,9-tetrahydro-1H-carbazol-1-yl)acetate 
• 800377-02-0 methyl [(1R)-9-[(1R)-1-(4-chlorophenyl)-2-hydroxyethyl]-6-fluoro-8-(methylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-1-yl]acetate 
• 800377-00-8 methyl [(1R)-9-[(1R)-2-{[tert-butyl(dimethyl)silyl]oxy}-1-(4-chlorophenyl)ethyl]-6-fluoro-8-(methylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-1-yl]acetate 

Relevant articles and documents

Potent and highly selective DP1 antagonists with 2,3,4,9-tetrahydro-1H- carbazole as pharmacophore

We discovered that the introduction of a methyl group to the benzylic position of the N-benzyl group in lead compound 1a has a dramatic effect on improving the binding selectivity of this ligand for the prostanoid receptors DP1 (receptor for prostaglandin

NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT

The present invention encompasses compounds of Formula I: as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating dyslipidemias. Pharmaceutical compositions and methods of use are also included.

METHOD OF TREATING ATHEROSCLEROSIS, DYSLIPIDEMIAS AND RELATED CONDITIONS

A method of treating atherosclerosis is disclosed wherein nicotinic acid or another nicotinic acid receptor agonist is administered to the patient in combination with a DP receptor antagonist. The DP receptor antagonist is administered to reduce, prevent